Gabapentin API Market
Gabapentin API Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Gabapentin API Market Size and Growth
The Gabapentin API market is experiencing significant growth due to rising demand for pain management therapies and increasing neurological disorder prevalence. In 2023, the market size is estimated at approximately $1.5 billion, with an expected CAGR of 6% through 2030, driven by advancements in production technologies and expanding applications.
Companies Covered
(Covid 19 Impact Covered)
◍ IOL Chemicals and Pharmaceuticals
◍ LGM Pharma
◍ Metrochem API
◍ Suanfarma
◍ HRV Global
◍ Zeon Pharma
◍ Amara Labs
◍ APIPL
◍ Aspen Biopharma
◍ Beloorbayir Biotech
◍ Divi's Laboratories
◍ Dongbang FTL
◍ Tosun Pharmaceutical
◍ Senwayer Century Chemical
◍ Wuhan Hengheda Pharm
The Gabapentin API market features companies like IOL Chemicals, LGM Pharma, and Divi's Laboratories, driving growth through diverse manufacturing capabilities and global distribution. Their strategic partnerships, product innovations, and expansion into emerging markets enhance market accessibility. Sales figures include IOL Chemicals at approximately $100 million and Divi's Laboratories at around $600 million.
Request Sample Report
Market Segmentation
By Application By Product
Epilepsy ◍ Neuropathic Pain ◍ Restless Legs Syndrome ◍ Others
Request Sample Report
Below 98%
Above 98%
Market Growth
Request Sample Report
$ X Billion USD
